Leukaemia-associated immunophenotypes (LAIP) are observed in 90% of adult and childhood acute lymphoblastic leukaemia: detection in remission marrow predicts outcome-Reference-Cited by-同舟云学术

Leukaemia-associated immunophenotypes (LAIP) are observed in 90% of adult and childhood acute lymphoblastic leukaemia: detection in remission marrow predicts outcome

Published:1999-04 Issue:1 Volume:105 Page:241-255
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Griesinger Frank,Piro-Noack Markus,Kaib Niels,Falk Michael,Renziehausen Anja,Troff Carmen,Grove Doris,Schnittger Susanne,Buchner Thomas,Ritter Jorg,Hiddemann Wolfgang,Wormann Bernhard

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.1999.01300.x/fullpdf

Reference39 articles.

1. Lack of CD45 antigen on blast cells in childhood acute lymphoblastic leukemia is associated with chromosomal hyperdiploidy and other favorable prognostic features [see comments]

2. Applications of cytometry to study acute leukemia: In vitro determination of drug sensitivity and detection of minimal residual disease

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunophenotypic portrait of leukemia‐associated‐phenotype markers in B acute lymphoblastic leukemia;Cytometry Part B: Clinical Cytometry;2023-11-30

2. Immunophenotypic expression and immunomodulation in minimal residual disease analysis of pediatric B acute lymphoblastic leukemia by high sensitive flow cytometry;Leukemia & Lymphoma;2021-11-02

3. Critical evaluation of the utility of pre- and post-therapy immunophenotypes in assessment of measurable residual disease in B-ALL;Annals of Hematology;2021-07-08

4. Precursor B-lineage acute lymphoblastic leukemia patients with aberrant natural killer cell and T cell – lineage antigen expression: experience from a tertiary cancer care center;Hematology, Transfusion and Cell Therapy;2020-10

5. A seven-color panel including CD34 and TdT could be applied in >97% patients with T cell lymphoblastic leukemia for minimal residual disease detection independent of the initial phenotype;Leukemia Research;2018-09